Peter Lynch · Growth at a reasonable price (GARP)
Is West Pharmaceutical Services, Inc. (WST) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria, growth too low or price too high.
24/100
Não encaixa
3/6 critérios atendidos
Os critérios de Peter Lynch, aplicados a WST
PEG ≤ 1.0
chave-
EPS CAGR ≥ 15%
chave-6.4%
Revenue CAGR ≥ 10%
2.1%
Net margin > 0
16.9%
Como WST pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$25.69B
P/L (TTM)
39.8x
ROIC (TTM)
15.24%
Margem bruta
36.24%
Outras análises Peter Lynch
Perguntas frequentes
What is WST's Peter Lynch fit score?
WST scores 24/100 on our Peter Lynch fit engine. Does not fit Lynch's GARP criteria, growth too low or price too high.
Does Peter Lynch actually own WST?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends WST.
How often is this score updated?
WST's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Peter Lynch possua ou recomende WST pessoalmente.
